Beam Therapeutics to Participate in Investor Conferences, Highlights Biotechnology Leadership

Marvell (MRVL) received a Buy rating from Christian Schwab at Craig-Hallum and Aaron Rakers at Wells Fargo. The company's shares closed at $73.00 last Friday. Schwab has a 53.56% success rate on recommended stocks and an average return of 8.2%. MRVL has a market cap of $62.94B and a P/E ratio of -127.22. Corporate insider sentiment is negative, with 76 insiders selling shares over the past quarter.

Title: Marvell Technology (MRVL) Faces Analyst Downgrade Amid Mixed Institutional Sentiment

Marvell Technology (MRVL) experienced a slight decline in its stock price on Thursday after investment firm KGI Securities downgraded the specialty semiconductor company from Outperform to Neutral [1]. The downgrade was accompanied by a reduction in the price target from $95 to $75. Despite this, the company reported a 63.3% year-over-year revenue increase and a quarterly EPS of $0.62, which exceeded consensus estimates [2].

The institutional investment landscape for Marvell has been dynamic. Quantitative Investment Management LLC, a quantitative investment firm, acquired a significant stake in Marvell Technology in the first quarter, purchasing 205,994 shares valued at approximately $12.68 million [2]. Additionally, several other institutional investors have bolstered their positions in Marvell Technology, including Bank Pictet & Cie Europe AG and Coppell Advisory Solutions LLC [2].

Analysts have been mixed in their ratings for Marvell Technology. While Loop Capital and KeyCorp reduced their target prices, Wall Street Zen downgraded the stock from a "buy" to a "hold" rating [2]. Conversely, Melius Research raised their target price to $76.00 and B. Riley set a $115.00 target price, indicating a "buy" rating [2]. Overall, Marvell Technology currently has an average rating of "Moderate Buy" and an average price target of $94.70 [2].

Corporate insider sentiment remains negative, with 76 insiders selling shares over the past quarter, including CFO Willem A. Meintjes and EVP Mark Casper [2]. Despite the insider selling, the company's stock closed at $73.00 last Friday, following a Buy rating from Christian Schwab at Craig-Hallum and Aaron Rakers at Wells Fargo [2]. Schwab has a 53.56% success rate on recommended stocks and an average return of 8.2% [2].

Looking ahead, analysts on Wall Street project that Marvell Technology will announce quarterly earnings of $0.67 per share, representing a 123.3% year-over-year increase [3]. Revenues are projected to reach $2.01 billion, up 58% from the same quarter last year [3]. The company's market cap stands at $62.94 billion with a P/E ratio of -127.22 [2].

References:
1. [1] https://seekingalpha.com/news/4488021-marvell-technology-slips-amid-kgi-securities-downgrade
2. [2] https://www.marketbeat.com/instant-alerts/filing-quantitative-investment-management-llc-takes-1268-million-position-in-marvell-technology-inc-mrvl-2025-08-24/
3. [3] https://finance.yahoo.com/news/wall-streets-insights-key-metrics-131502459.html